Research has found that understanding the "program" of pancreatic aging can help in the early prevention of diabetes.

A new study led by French researchers has found that pancreatic aging is not the disordered decline previously believed, but rather an orderly process closely related to epigenetic mechanisms. The study found that as individuals age, changes in the pancreas follow a biological "program," with methylation and other epigenetic changes occurring in specific regions of the related DNA sequences. These changes are not random, but rather concentrated in areas crucial for maintaining the normal function of pancreatic islet cells and insulin secretion. This suggests that pancreatic aging may, to some extent, be an adaptive process that helps maintain metabolic health. However, in individuals with type 2 diabetes, the epigenetic changes related to pancreatic cells present a significantly different picture from normal aging: diabetes disrupts gene expression related to insulin secretion in a disordered manner, leading to cellular stress and inflammation. This finding opens up a new pathway for better understanding and preventing diabetes. The related research paper has been published in the journal Nature Communications in the UK.